Ekso Bionics Holdings, Inc.
EKSO
$0.4046
$0.02476.50%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.01% | -10.38% | 5.25% | -8.88% | 36.50% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.01% | -10.38% | 5.25% | -8.88% | 36.50% |
| Cost of Revenue | -4.12% | -10.74% | -5.55% | -14.94% | 32.30% |
| Gross Profit | 14.56% | -10.06% | 16.99% | -2.45% | 41.18% |
| SG&A Expenses | -7.24% | -3.71% | -24.98% | -23.10% | -12.47% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.76% | -10.21% | -18.94% | -18.18% | 3.87% |
| Operating Income | 35.34% | 9.96% | 45.49% | 26.80% | 22.25% |
| Income Before Tax | -6.19% | 38.42% | 42.88% | 21.87% | -1.13% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.19% | 38.42% | 42.88% | 21.87% | -1.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.19% | 38.42% | 42.88% | 21.87% | -1.13% |
| EBIT | 35.34% | 9.96% | 45.49% | 26.80% | 22.25% |
| EBITDA | 39.28% | 10.97% | 49.74% | 29.35% | 27.79% |
| EPS Basic | 37.75% | 57.34% | 57.25% | 40.35% | 7.87% |
| Normalized Basic EPS | 37.74% | 57.30% | 57.25% | 42.27% | 7.82% |
| EPS Diluted | 38.80% | 57.34% | 57.25% | 40.35% | 6.29% |
| Normalized Diluted EPS | 37.74% | 57.30% | 57.25% | 42.27% | 7.82% |
| Average Basic Shares Outstanding | 70.57% | 44.32% | 33.64% | 31.01% | 9.77% |
| Average Diluted Shares Outstanding | 70.57% | 44.32% | 33.64% | 31.01% | 9.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
